Traditional Chinese medicine faces the overall delisting risk in European Union

Traditional Chinese medicine faces the overall delisting risk in European Union
According to the regulation that " traditional plant medicine registers the procedure to make " of European Union, from April, reaching relevantly and registering standard traditional plant medicine will forbid selling within the range of European Union. Seeing that still there is not traditional Chinese medicine so far " Wash and close " Succeeding, traditional Chinese medicine may quit listing in European Union in an all-round way, the traditional Chinese medicine personnel obtaining employment in European Union will face " have no rice to cook " Situation.
It is reported, on March 31, 2004, European Union issued " the registered procedure of traditional plant medicine made ". This decree stipulates, all plant medicines sold on European Union market must be according to registration of this new regulation, continue selling after being listed and permit. Meanwhile, this decree stipulated the transition period of 7, the medical herbs products allowed to sell in country of European Union with various identities such as food were sold until March 31, 2011. " limit in 7 years " Inside, want to continue keeping and must reach and register the standard in the products of European Union's market sales.
After this decree is issued, some traditional Chinese medicine enterprises make great efforts actively. But up to March 31 this year, still there is not traditional Chinese medicine that obtain " break-through of zero " in registering according to the new regulation . The relevant expert analyzes, " wash, close " traditional Chinese medicine There are two main difficult problems faced: First, " traditional plant medicine registers the procedure to make " to stipulate, traditional medical herbs applied for the registration should offer it to already use history to prove for 15 years at least in European Union in European Union. A classical Chinese medicine that and six flavor digitalis pills, white phoenix pills of dark chicken,etc. are known very well and approved by patient of European Union, although had already entered European Union market as early as 1995 ago, it had identification of using history on the markets of EU countries in 15 years that it is difficult to offer. Second, it is costly to register, the medicine enterprise can't bear the heavy load. It is reported, traditional Chinese medicine of an enterprise is if according to the regulation registration of " traditional plant medicine register the procedure to make ", the registration charges probably needs 800,000 yuan; Authorize through European Union GMP, makes the investment when the hardware with production equipment it costs more than 4 million yuan; And the training, expert instruct,etc. the investment of software also needs to be about 4 million yuans.
It is reported, European Union is a main market of plant medicine in the world, the annual sales amount reaches tens of billions euro. Though 7 time limit has already passed, the possibility that our country is still trying to continue applying actively at present. The relevant trade organization of imports and exports of traditional Chinese medicine of our country calls upon European Union to register time to lengthen until 2019.
|